Amneal Pharmaceuticals and AvKARE have entered into a definitive agreement under which Amneal will acquire a 65.1% majority interest in AvKARE and its related affiliate doing business ...
Amneal Pharmaceuticals has agreed to buy a 65.1% stake in pharmaceuticals manufacturer and wholesaler AvKARE and its affiliate R&S Northeast for approximately $340m.